Heart rate variability and progression of coronary atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 8, 1999, Pages 1979-1985

  Huikuri, Heikki V ^a   Jokinen, Vesa ^b   Syvänne, Mikko ^b   Nieminen, Markku S ^b   Airaksinen, K E Juhani ^b   Ikäheimo, Markku J ^b   Koistinen, Juhani M ^b   Kauma, Heikki ^b   Kesäniemi, Antero Y ^b   Majahalme, Silja ^b   Niemelä, Kari O ^b   Frick, M Heikki ^b  

^a UNIVERSITY OF OULU   (Finland)

^b NONE

Author keywords

Angiography; Coronary artery disease; Heart period; Lipids

Indexed keywords

GEMFIBROZIL; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 0032777203     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.8.1979     Document Type: Article

References (35)

1. Kannel WB, Kannel C, Paffenbarger RS, Cupples LA. Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J. 1987;113: 1489-1494.
2. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: The NHANES I Epidemilogical Follow-up Study. Am Heart J. 1991;121:172-177.
3. Mensink GBM, Hoffmeister H. The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J. 1997;18:1404-1410.
4. Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicord P, Henning H, Ross J Jr. Influence of heart rate on mortality after myocardial infarction. Am J Cardiol. 1990;65:547-551.
5. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ, and the Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-262.
6. Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Klieger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 1992;85:164-171.
7. Tsuji H, Larson MG, Venditti FJ, Manders ES, Evans JC, Feldman CL, Levy D. Impact of reduced heart rate variability on risk for cardiac events: The Framingham Heart Study. Circulation. 1996;94:2850-2855.
8. Filipovsky J, Ducimetiere P, Safar ME. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension. 1992;20:333-339.
9. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science. 1984;226:180-182.
10. Kaplan JR, Manuck SB, Adams MR, Weingard KW, Clarkson TB. Inhibition of coronary atherosclerosis by propranolol on behaviorally predisposed monkeys fed an atherogenic diet. Circulation. 1987;86: 1364-1372.
11. Kaplan JR, Manuck SB, Clarkson TB. The influence of heart rate on coronary atherosclerosis. J Cardiovasc Pharm. 1987;10(suppl 2):S100-S102.
12. Sa Cunha R, Pannier B, Benetos A, Siche J-P, London GM, Mallion JM, Safar ME. Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertension. 1997;15: 1423-1430.
13. Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, Williams PT, Johnstone IM, Champagne MA, Krauss RM, Farquliar JW. Effects of intensive multiple risk factor reductions on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: The Stanford Coronary Risk Intervention Project. Circulation. 1994;89:975-990.
14. Gotto AM Jr. Lipid lowering, regression and coronary events: a review of the Interdisciplinary Council of Lipids and Cardiovascular Risk Intervention, Seventh Council Meeting. Circulation. 1995;92:646-656.
15. Schwartz CJ, Mitchell JRA. Observations on localization of arterial plaques. Circ Res. 1972;11:63-73.
16. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990;15:1667-1687.
17. Asakura T, Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Res. 1990;66: 1045-1066.
18. Hamsten A. Hemostatic function and coronary artery disease. N Engl J Med. 1995;332:677-678.
19. Frick MH, Syvänne M, Nieminen MS, Kauma H, Majahalme S, Virtanen V, Kesäniemi YA, Pasternack A, Taskinen M-R, for the Lopid Coronary Angiography Trial (LOCAT) Study Group. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Circulation. 1997;96:2137-2143.
20. Syvänne M, Taskinen M-R, Nieminen MS, Manninen V, Kesäniemi YA, Pasternack A, Nawrocki JW, Haber H, Frick MH. A study to determine the response of coronary atherosclerosis to raising low HDL cholesterol with a fibric-acid derivative in men after coronary bypass surgery: the rationale, design and baseline characteristics of the LOCAT study. Control Clin Trials. 1997;18:93-119.
21. Syvänne M, Nieminen MS, Frick MH. Accuracy and precision of quantitative arteriography in the evaluation of coronary artery disease after coronary bypass surgery: a validation study. Int J Vasc Imaging. 1994; 10:243-252.
22. Huikuri HV, Niemelä MJ, Ojala S, Rantala A, Ikäheimo MJ, Airaksinen KEJ. Circadian rhythms of frequency domain measures of heart rate variability in healthy subjects and patients with coronary artery disease: effects of arousal and upright posture. Circulation. 1994;90:121-126.
23. Huikuri HV, Mäkikallio TH, Airaksinen KEJ, Seppänen T, Puukka, P, Räihä IJ, Sourander LB. Power law relationship of heart rate variability as a predictor of mortality in the elderly. Circulation. 1998;97:2031-2036.
24. Hartikainen JEK, Malik M, Staunton A, Poloniecki J, Camm AJ. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction. J Am Coll Cardiol. 1996;28:296-304.
25. Perkiömäki JS, Huikuri HV, Koistinen MJ, Mäkikallio T, Castellanos A, Myerburg RJ. Heart rate variability and dispersion of QT interval in patients with vulnerability to ventricular tachycardia and ventricular fibrillation after previous myocardial infarction. J Am Coll Cardiol. 1997;30:1331-1338.
26. Perski A, Olsson G, Laudon C, deFaire V, Theorell T, Hamsten A. Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J. 1992;123: 609-616.
27. Bergel DH, Brooks DE, MacDermott AJ, Robinson JL, Sleight P. Baroreceptor firing frequency and activation of carotid sinus vascular smooth muscle in dogs. J Physiol. 1978;275:37P-38P.
28. Caro CG, Fitz-Gerald JM, Schroter RC. Arterial wall shear and distribution of early atheroma in man. Nature. 1969;223:1159-1161.
29. Sprague EA, Steinbach BL, Nerem RM, Schwartz CJ. Influence of laminar steady-state fluid-imposed wall shear stress on the binding, internalization, and degradation of low-density lipoproteins by cultured arterial endothelium. Circulation. 1987;76:648-656.
30. Predel, HG, Yang Z, von Segesser L, Turina M, Bühler FR, Lüscher TF. Implications of pulsatile stretch on growth of saphenous vein and mammary artery smooth muscle. Lancet. 1992;340:878-879.
31. Yellin EL. Laminar-turbulent transition process in pulsatile flow. Circ Res. 1966;19:791-804.
32. Jones PJH, Schoeller DA. Evidence for diurnal periodicity in human cholesterol synthesis. J Lipid Res. 1990;31:667-673.
33. Kukreja RS, Datta BN, Chakra-Varti RN. Catecholamine-induced aggravation of aortic and coronary atherosclerosis in monkeys. Atherosclerosis. 1981;40:291-298.
34. Yu S-M, Tsai S-Y, Guh J-H, Ko F-N, Teng C-M, Ou J-T. Mechanisms of catecholamine-induced proliferation of vascular smooth muscle cells. Circulation. 1996;94:547-554.
35. Dzau VJ, Sarbs FM. Regulation of lipoprotein metabolism by adrenergic mechanisms. J Cardiovasc Pharmacol. 1987;10(suppl 9):S2-S6.